Patents by Inventor Christopher McKinnon
Christopher McKinnon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240042036Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: September 29, 2023Publication date: February 8, 2024Applicant: Fennec Pharmaceuticals IncInventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230201350Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: February 20, 2023Publication date: June 29, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230201351Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: February 20, 2023Publication date: June 29, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230201349Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: February 20, 2023Publication date: June 29, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230158145Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: November 22, 2022Publication date: May 25, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Patent number: 11617793Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: GrantFiled: July 22, 2022Date of Patent: April 4, 2023Assignee: Fennec Pharmaceuticals, Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher Mckinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230094842Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: November 22, 2022Publication date: March 30, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20220378915Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: July 22, 2022Publication date: December 1, 2022Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Patent number: 11510984Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: GrantFiled: June 24, 2022Date of Patent: November 29, 2022Assignee: Fennec Pharmaceuticals, Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20220323586Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: June 24, 2022Publication date: October 13, 2022Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20220160875Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: January 25, 2022Publication date: May 26, 2022Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Patent number: 11291728Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum based chemotherapeutics.Type: GrantFiled: August 28, 2020Date of Patent: April 5, 2022Assignee: FENNEC PHARMACEUTICALS, INC.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20210015923Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum based chemotherapeutics.Type: ApplicationFiled: August 28, 2020Publication date: January 21, 2021Inventors: Thomas Claiborne LOVELACE, Joseph Alexander MOORE, III, Christopher McKinnon LEE, Daniel Logan KIRSCHNER
-
Patent number: 10792363Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum based chemotherapeutics.Type: GrantFiled: July 1, 2019Date of Patent: October 6, 2020Assignee: FENNEC PHARMACEUTICALS, INC.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20200023003Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum based chemotherapeutics.Type: ApplicationFiled: July 1, 2019Publication date: January 23, 2020Inventors: Christopher McKinnon LEE, Thomas Claiborne LOVELACE, Joseph Alexander MOORE, III, Daniel Logan KIRSCHNER
-
Publication number: 20200009255Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum based chemotherapeutics.Type: ApplicationFiled: July 1, 2019Publication date: January 9, 2020Inventors: Thomas Claiborne LOVELACE, Joseph Alexander MOORE, III, Christopher McKinnon LEE, Daniel Logan KIRSCHNER
-
Publication number: 20080255971Abstract: This invention relates to a method and system of self-auditing for recovering refundable sales taxes, including but not limited to value-added (VAT), by performing specifically established tax compliance algorithmic functions. Business entities are entitled to recover tax paid on purchased goods and services. The method and system allow the business to conduct self-audit on their own accounting system, which contains its business related accounts payable accounting transaction data in order to extract specific data anomalies related to sales tax entitlements. The method and system process and identify specific transaction details and calculate differential monetary currency tax recovery amounts that have been overlooked as tax entitlements or overpaid in error to vendors for their determination of their net tax owing to various government bodies.Type: ApplicationFiled: April 10, 2007Publication date: October 16, 2008Applicant: EPIPHANY STAR LTD.Inventors: Christopher McKinnon, Edward Hajdasz